TB cost of care_GF in Cameroun
In the years 2006 – 2013, Cameroon received over USD 19 million to treat Tuberculosis (TB). Forty nine percent of that funding came from one donor, the Global Fund (www.theglobalfund.org), and forty three percent came from domestic sources (i.e. government plus loans).
In a nutshell, the Global Fund is supporting about half to two thirds of the cost of each notified case of TB found and treated in Cameroon. This is unsustainable and high risk.
The average cost of treatment/service per TB cases notified during this period was USD96 – of which the Global Fund provided about USD41 per patient. The government spent on average USD 46 per patient.
Considering the rise in reported TB cases, and despite the current funding coming from domestic sources there is need for the Government of Cameroon to increase its financial contributions, particularly to prevent interrupted treatment and improve adherence.
TB remains among the top most causes of death in Cameroon alongside HIV/AIDS and Malaria. According to estimates by World Health Organization (WHO), the incidence of TB in Cameroon was 118 cases per 100,000 people in 2013 up from 177 cases per 100,000 people in 2010 (NTP Cameroon, 2012). The increase in cases reported may be attributed also to better case detection particularly among HIV positive patients. Detection and numbers of patients treated for multi-drug resistant TB (MDR TB) has also increased by over 400% in last 4 years. The increase in treatment expenses for MDRTB patients does not match budget increases. Also, as these treatment expenses increase, other areas of TB control may suffer.